Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate immune mechanisms of mRNA vaccines
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215

Showing 1-25 of 215 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 58
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 52
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 39
Recent advances in nanoparticulate RNA delivery systems
Jacob Witten, Yizong Hu, Róbert Langer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 36
PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 19
Myocarditis associated with COVID-19 vaccination
Alessandra Buoninfante, Arno C. Andeweg, Georgy Genov, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 1
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Christin Schmidt, Barbara S. Schnierle
Pathogens (2023) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 37
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
Laura Matarazzo, Paulo Bettencourt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
The advances of adjuvants in mRNA vaccines
C. Xie, Ruhui Yao, Xiaojun Xia
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Diana D. Kang, Haoyuan Li, Yizhou Dong
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114961-114961
Open Access | Times Cited: 34
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M. Leal, Adrian Simpson, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2360-2375
Open Access | Times Cited: 27
Trained immunity: Target for prophylaxis and therapy
Athanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1776-1791
Open Access | Times Cited: 26
Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method
Manon Berger, Manon Degey, Jeanne Leblond, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 597-597
Open Access | Times Cited: 25
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
Yue Xu, Alex Golubovic, Shufen Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 28, pp. 6527-6539
Closed Access | Times Cited: 24
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
Francesco Ursini, Piero Ruscitti, Olga Addimanda, et al.
RMD Open (2023) Vol. 9, Iss. 2, pp. e003022-e003022
Open Access | Times Cited: 23
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1266-1283
Open Access | Times Cited: 12
mRNA Vaccine Nanoplatforms and Innate Immunity
Lai Wei, Chunhong Dong, Wandi Zhu, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 11
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top